data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Glaukos
(NYSE:GKOS)
$47.64
2.22[4.89%]
At close: Jul 1
$47.66
0.0200[0.04%]
After Hours: 4:03PM EDT
Day High/Low45.11 - 47.75
52 Week High/Low33.33 - 86.35
Open / Close45.28 / 47.66
Float / Outstanding27.9M / 47.3M
Vol / Avg.278.1K / 506.9K
Mkt Cap2.3B
P/E-
50d Avg. Price43.54
Div / Yield-
Payout Ratio-
EPS0.11
Total Float27.9M

Glaukos (NYSE:GKOS), Quotes and News Summary

Glaukos (NYSE: GKOS)

Day High/Low45.11 - 47.75
52 Week High/Low33.33 - 86.35
Open / Close45.28 / 47.66
Float / Outstanding27.9M / 47.3M
Vol / Avg.278.1K / 506.9K
Mkt Cap2.3B
P/E-
50d Avg. Price43.54
Div / Yield-
Payout Ratio-
EPS0.11
Total Float27.9M
Benzinga - May 17, 2022, 8:06AM
Benzinga - May 4, 2022, 4:20PM
Benzinga - May 4, 2022, 4:18PM
Benzinga - Mar 25, 2022, 7:08AM
Benzinga - Mar 14, 2022, 7:24AM
Benzinga - Feb 23, 2022, 11:23AM
Benzinga - Feb 23, 2022, 8:31AM
Benzinga - Feb 22, 2022, 4:39PM
Benzinga - Feb 22, 2022, 4:38PM
Benzinga - Feb 7, 2022, 4:25PM
Benzinga - Feb 3, 2022, 7:15AM
Benzinga - Jan 19, 2022, 6:15AM
Benzinga - Jan 18, 2022, 10:02AM
Benzinga - Jan 12, 2022, 5:47AM
Benzinga - Jan 11, 2022, 4:12PM
Benzinga - Jan 11, 2022, 4:12PM
Benzinga - Jan 11, 2022, 4:11PM
Benzinga - Jan 6, 2022, 4:13PM
Benzinga - Dec 20, 2021, 4:16PM
Benzinga - Nov 11, 2021, 7:25AM
Benzinga - Nov 5, 2021, 9:42AM
Benzinga - Nov 4, 2021, 4:40PM
Benzinga - Nov 4, 2021, 4:39PM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.500-0.380 0.1200
REV60.850M67.681M6.831M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Glaukos Questions & Answers

Q
How do I buy Glaukos (GKOS) stock?
A

You can purchase shares of Glaukos (NYSE: GKOS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Glaukos's (GKOS) competitors?
Q
What is the target price for Glaukos (GKOS) stock?
A

The latest price target for Glaukos (NYSE: GKOS) was reported by Citigroup on Tuesday, May 17, 2022. The analyst firm set a price target for 43.00 expecting GKOS to fall to within 12 months (a possible -9.74% downside). 12 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Glaukos (GKOS)?
A

The stock price for Glaukos (NYSE: GKOS) is $47.64 last updated July 1, 2022, 7:59 PM UTC.

Q
Does Glaukos (GKOS) pay a dividend?
A

There are no upcoming dividends for Glaukos.

Q
When is Glaukos (NYSE:GKOS) reporting earnings?
A

Glaukos’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Glaukos (GKOS) going to split?
A

There is no upcoming split for Glaukos.

Q
What sector and industry does Glaukos (GKOS) operate in?
A

Glaukos is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.